top of page

Topic

Histotripsy

4 Podcasts • 1 Course on BackTable

Hear how experienced physicians approach Histotripsy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Optimizing Liver-Directed Interventions for Neuroendocrine Tumors
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 72  •  14 Jul 2026

Optimizing Liver-Directed Interventions for Neuroendocrine Tumors

What factors come into play when deciding whether to use liver-directed therapy or systemic therapies for neuroendocrine tumors? In this episode of the BackTable Tumor Board Podcast, Dr. Lingling Du, Dr. Chih-Yi Liao, and Dr. Abdul Khan discuss the structure of a multidisciplinary tumor board and how they approach decision-making for patients with neuroendocrine tumors. The conversation explores who benefits most from liver-directed therapy, optimal timing for intervention, and the importance of individualized treatment planning.

More on Histotripsy

Loading recent podcasts…

Tumor Board

Tumor Board # 72

Jul 13, 2026

with Dr. Chih-Yi Liao, Dr. Abdul Khan, Dr. Lingling Du

Optimizing Liver-Directed Interventions for Neuroendocrine Tumors

What factors come into play when deciding whether to use liver-directed therapy or systemic therapies for...

VI

Vascular & IR # 515

Feb 6, 2025

with Dr. Kirema Garcia-Reyes, Dr. Kevin Burns, Dr. Sabeen Dhand, Dr. Zach Berman, Dr. Tyler Sandow

Curative Intent Therapies for HCC: Today & Tomorrow

For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation...

2,000+ listens

Tumor Board

Tumor Board # 62

Jun 1, 2026

with Dr. Rebekah White, Dr. Michael Sherer, Dr. Zach Berman

Advancements in Managing Locally Advanced Pancreatic Cancer

Can a tumor deemed permanently unresectable actually be downstaged to surgery? In this episode of BackTable Tumor...

Tumor Board

Tumor Board # 4

Jan 16, 2025

with Dr. Kirema Garcia-Reyes, Dr. Kevin Burns, Dr. Sabeen Dhand, Dr. Zach Berman, Dr. Tyler Sandow

Curative Intent Therapies for HCC: Today & Tomorrow

For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation...

Y90 Dosing & Ablation Modalities for HCC

Tumor Board Course

2 hours, 20 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page